1. Home
  2. DPRO vs CVM Comparison

DPRO vs CVM Comparison

Compare DPRO & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • CVM
  • Stock Information
  • Founded
  • DPRO 1998
  • CVM 1983
  • Country
  • DPRO Canada
  • CVM United States
  • Employees
  • DPRO N/A
  • CVM N/A
  • Industry
  • DPRO Aerospace
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DPRO Industrials
  • CVM Health Care
  • Exchange
  • DPRO Nasdaq
  • CVM Nasdaq
  • Market Cap
  • DPRO 81.2M
  • CVM 71.2M
  • IPO Year
  • DPRO N/A
  • CVM 1987
  • Fundamental
  • Price
  • DPRO $5.17
  • CVM $8.89
  • Analyst Decision
  • DPRO Strong Buy
  • CVM
  • Analyst Count
  • DPRO 2
  • CVM 0
  • Target Price
  • DPRO $6.50
  • CVM N/A
  • AVG Volume (30 Days)
  • DPRO 1.4M
  • CVM 297.1K
  • Earning Date
  • DPRO 11-13-2025
  • CVM 08-14-2025
  • Dividend Yield
  • DPRO N/A
  • CVM N/A
  • EPS Growth
  • DPRO N/A
  • CVM N/A
  • EPS
  • DPRO N/A
  • CVM N/A
  • Revenue
  • DPRO $5,250,872.00
  • CVM N/A
  • Revenue This Year
  • DPRO $41.59
  • CVM N/A
  • Revenue Next Year
  • DPRO $132.11
  • CVM N/A
  • P/E Ratio
  • DPRO N/A
  • CVM N/A
  • Revenue Growth
  • DPRO 17.08
  • CVM N/A
  • 52 Week Low
  • DPRO $1.63
  • CVM $1.98
  • 52 Week High
  • DPRO $7.31
  • CVM $38.70
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 57.24
  • CVM 46.09
  • Support Level
  • DPRO $4.99
  • CVM $9.58
  • Resistance Level
  • DPRO $5.40
  • CVM $12.68
  • Average True Range (ATR)
  • DPRO 0.32
  • CVM 1.08
  • MACD
  • DPRO 0.06
  • CVM -0.38
  • Stochastic Oscillator
  • DPRO 79.09
  • CVM 2.68

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: